The pharma MSMEs have recommended to the Union health ministry a case-by-case extension mechanism to implement revised Schedule M. It has been recommended that a case-by-case extension mechanism may ...
The pharmaceutical industry has reiterated its support for the objectives of India's revised Schedule M, while simultaneously highlighting growing concerns over ambiguities in the interpretation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results